Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael T Sweeney

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Antimicrobial Agents and Chemotherapy|May 23, 2003
In vitro activities of linezolid combined with other antimicrobial agents against Staphylococci, Enterococci, Pneumococci, and selected gram-negative organismsMichael T Sweeney, Gary E Zurenko
The Veterinary Clinics of North America. Food Animal Practice|February 2, 2010
Antimicrobial resistance in bovine respiratory disease pathogens: measures, trends, and impact on efficacyJeffrey L Watts, Michael T Sweeney
Journal of Veterinary Pharmacology and Therapeutics|March 1, 2020
Current and future perspectives on the categorization of antimicrobials used in veterinary medicineJeffrey L Watts, Michael T Sweeney, Brian V Lubbers
Microbiology Spectrum|March 31, 2018
Antimicrobial Susceptibility Testing of Bacteria of Veterinary OriginJeffrey L Watts, Michael T Sweeney, Brian V Lubbers
Veterinary Therapeutics : Research in Applied Veterinary Medicine|November 13, 2008
In vitro activities of tulathromycin and ceftiofur combined with other antimicrobial agents using bovine Pasteurella multocida and Mannheimia haemolytica isolatesMichael T Sweeney, Gordon W Brumbaugh, Jeffrey L Watts
Journal of Veterinary Diagnostic Investigation : Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc|January 10, 2017
New interpretive criteria for danofloxacin antibacterial susceptibility testing against Mannheimia haemolytica and Pasteurella multocida associated with bovine respiratory diseaseMichael T Sweeney, Mark G Papich, Jeffrey L Watts
The Journal of Antimicrobial Chemotherapy|December 19, 2018
Plasmid-located extended-spectrum β-lactamase gene blaROB-2 in Mannheimia haemolyticaKristina Kadlec, Jeffrey L Watts, Stefan Schwarz, et al.
The Journal of Antimicrobial Chemotherapy|February 27, 2018
Applying definitions for multidrug resistance, extensive drug resistance and pandrug resistance to clinically significant livestock and companion animal bacterial pathogensMichael T Sweeney, Brian V Lubbers, Stefan Schwarz, et al.
Frontiers in Microbiology|June 21, 2013
In vitro activity and rodent efficacy of clinafloxacin for bovine and swine respiratory diseaseMichael T Sweeney, Rebecca Quesnell, Raksha Tiwari, et al.
Antimicrobial Agents and Chemotherapy|March 16, 2011
Molecular basis of macrolide, triamilide, and lincosamide resistance in Pasteurella multocida from bovine respiratory diseaseKristina Kadlec, Geovana Brenner Michael, Michael T Sweeney, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Antimicrobial Agents and Chemotherapy|May 23, 2003
In vitro activities of linezolid combined with other antimicrobial agents against Staphylococci, Enterococci, Pneumococci, and selected gram-negative organismsMichael T Sweeney, Gary E Zurenko
The Veterinary Clinics of North America. Food Animal Practice|February 2, 2010
Antimicrobial resistance in bovine respiratory disease pathogens: measures, trends, and impact on efficacyJeffrey L Watts, Michael T Sweeney
Journal of Veterinary Pharmacology and Therapeutics|March 1, 2020
Current and future perspectives on the categorization of antimicrobials used in veterinary medicineJeffrey L Watts, Michael T Sweeney, Brian V Lubbers
Microbiology Spectrum|March 31, 2018
Antimicrobial Susceptibility Testing of Bacteria of Veterinary OriginJeffrey L Watts, Michael T Sweeney, Brian V Lubbers
Veterinary Therapeutics : Research in Applied Veterinary Medicine|November 13, 2008
In vitro activities of tulathromycin and ceftiofur combined with other antimicrobial agents using bovine Pasteurella multocida and Mannheimia haemolytica isolatesMichael T Sweeney, Gordon W Brumbaugh, Jeffrey L Watts
Journal of Veterinary Diagnostic Investigation : Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc|January 10, 2017
New interpretive criteria for danofloxacin antibacterial susceptibility testing against Mannheimia haemolytica and Pasteurella multocida associated with bovine respiratory diseaseMichael T Sweeney, Mark G Papich, Jeffrey L Watts
The Journal of Antimicrobial Chemotherapy|December 19, 2018
Plasmid-located extended-spectrum β-lactamase gene blaROB-2 in Mannheimia haemolyticaKristina Kadlec, Jeffrey L Watts, Stefan Schwarz, et al.
The Journal of Antimicrobial Chemotherapy|February 27, 2018
Applying definitions for multidrug resistance, extensive drug resistance and pandrug resistance to clinically significant livestock and companion animal bacterial pathogensMichael T Sweeney, Brian V Lubbers, Stefan Schwarz, et al.
Frontiers in Microbiology|June 21, 2013
In vitro activity and rodent efficacy of clinafloxacin for bovine and swine respiratory diseaseMichael T Sweeney, Rebecca Quesnell, Raksha Tiwari, et al.
Antimicrobial Agents and Chemotherapy|March 16, 2011
Molecular basis of macrolide, triamilide, and lincosamide resistance in Pasteurella multocida from bovine respiratory diseaseKristina Kadlec, Geovana Brenner Michael, Michael T Sweeney, et al.
Pageof 3